Archive August 30, 2025

Newcastle sign Woltemade in club record £69m deal

Images courtesy of Getty
  • 657 Comments

Stuttgart striker Nick Woltemade has been signed for a six-year contract by Newcastle United, breaking club records.

The 23-year-old Germany international, who stands at 6′ 6″, has signed for Newcastle in a £69 million deal.

This surpasses the $63 million investment that Newcastle made three years ago, making Alexander Isak the club’s most expensive player.

Given the ongoing uncertainty surrounding Isak’s future, who is determined to join Liverpool, Woltemade will have a significant role to play going forward.

He expressed his delight at this incredible club, “absolutely.” I initially got the impression that the club was interested in and had big plans for me.

Everyone has welcomed me so warmly and it already feels like family, but it’s a big step in my life to leave Germany. Talking with the head coach gave me the impression that this is where I should be at my absolute best.

“I have seen games on television and have seen the stadium, and I know the atmosphere is crazy. I’m very excited to begin scoring goals here.

Eddie Howe, the head coach of Newcastle United, stated: “We’re delighted to have Nick’s signing over the line so quickly. He provides exactly what we were looking to add to our attacking options.

Analysis can reveal things can be deceiving

Woltemade appears to be a battering ram from a center forward at first glance, but that is completely untrue.

The powerful striker, who has been nicknamed “Woltemessi” by Bayern Munich goalkeeper Manuel Neuer, is technically gifted and adept at pulling his body out of tight spaces and linking play.

To cap a remarkable 12-month contract with Woltemade, Newcastle were persuaded to break their transfer record thanks to this distinctive profile.

Woltemade wasn’t even a household name in Germany until a year ago. When he joined Stuttgart as a free agent from Werder Bremen, he was not even guaranteed a starting position.

However, he has made some remarkable progress since then.

Woltemade won the first significant trophy of his career by winning 17 goals in 33 games for Stuttgart last year, including the German Cup final.

He then led Germany to the Under-21 World Cup final, where they lost to England in extra time, last month, and he led the group in scoring with six goals.

Woltemade won’t have much time to settle at Newcastle, incidentally, just like Isak did when he first joined the club three years ago and at a similar age and in the same window of opportunity. However, Under Howe and his staff, this is unmistakable.

Given the circumstances surrounding Isak and the short window of time, the black-and-whites will undoubtedly have felt they must make the move this summer.

After another impressive season in the Bundesliga, there is a very real chance that Woltemade, who also attracted bids from Bayern Munich, would have been unattainable.

However, it seems like Newcastle are not yet complete.

They are still active in the market and are interested in Brentford’s Yoane Wissa and Wolves’ Jorgen Strand Larsen.

There isn’t much time left for Wolves or Brentford to find a replacement before Monday’s 19:00 BST deadline, so neither deal would be simple to close. However, things can change quickly.

related subjects

  • Premier League
  • Transfers of football
  • Newcastle United
  • Football

Shoppers can grab ‘enchanting and long-lasting’ Vera Wang perfume for £8 with this offer

Due to this less well-known offer, Vera Wang’s iconic fragrance, which receives “so many compliments,” is currently available for a significantly reduced price of £8.40.

Shop ‘enchanting and long-lasting’ Vera Wang perfume for £8 with this offer(Image: Getty)

A cult-classic perfume boasting over 53k reviews, with a resounding 78% giving the fragrance five stars on Amazon, the much-loved Vera Wang Princess Perfume (100ml bottle) would normally set customers back £66, but thanks to this lesser-known deal, it’s now reduced to £8.40.

Customers can now get a 100ml bottle for the affordable price of £8.40 when they sign up for TopCashBack, which is currently available for the already-reduced price of £26 at Superdrug and Boots.

Although it may seem complicated, it is straightforward and cost-free. A brand-new TopCashback member will receive a complimentary £20 sign-up bonus (valid until midnight on August 31) and cashback on their purchases, lowering perfume by an incredible 87% from its full price. Simply purchase this “captivating” perfume through this special link to profit from this deal.

READ MORE: Strictly filming’s director Dani Dyer reveals the “long-lasting” setting spray she swears by.

READ MORE: Just in time for the first week of term, Amazon’s Kids Kindle is discounted.

Vera Wang Princess Eau de Toilette 100ml
This Vera Wang Princess Eau de Toilette (100ml) can be yours for £8 right now(Image: Vera Wang)

This floral fragrance, which combines “rich vanilla with exotic flowers and succulent fruits,” is described online as a fruity floral perfume. The retailer continued, “The scent sparkles with the entrancing, sweet, tart aroma of delicate lady apples and dreamy water lilies lightly kissed by golden apricot and mandarin meringue.”

Due to its enchanting blend of floral and fruity notes, which makes for a “versatile” and “feminine” fragrance that effortlessly transitions from occasion to occasion and is “seamlessly moving from day to night,” Vera Wang Princess has delighted customers who are gushing about it.

This scent transforms into a heart of pink guava, tiare flower, and dark chocolate, giving off an exotic sophistication by revealing the delicate top notes of apples, water lilies, and apricots. A base of warm amber and vanilla serves as the final touch for all of this, giving you the ideal, adaptable scent for any occasion.

Fans of the Princess scent can be expressed admiration in adoring testimonials, and one admirer writes, “It’s a lovely scent, very pleasant when I want to smell nice but not make a big statement about it.” People have told me that wearing it makes me smell good.

Use this perfume at work, another user said. It smells lovely and lasts all day. It has been purchased numerous times.

A true gem in the world of fragrances, according to a 5-star enthusiast. Its enchanting scent, versatile nature, stunning packaging, and long-lasting allure are all qualities that anyone seeking to channel their inner princess should have. Enjoy this fragrance’s magical charm and take pleasure in the royalty-like atmosphere that it brings to daily life.

Another customer praised the scent, saying, “My sister in law absolutely loved it!” She was immediately taken away by the elegant, long-lasting, and not-overpowering scent from the moment she applied it. The fragrance is ideal for both everyday wear and special occasions because it combines warm and floral notes perfectly. She has already made a decision to buy it again for herself because of how many compliments she received.

One delighted customer remarked, “Bought it as a gift for my sister, and she absolutely loves it. The scent is so lovely that it persists the following day.

This Princess fan also gave praise for saying, “I wasn’t wrong about this perfume and I had a good feeling about it. A must-have”.

Continue reading the article.

The gorgeous packaging also includes gold rings, giving you a gorgeous fragrance and some chic accessories that are appropriate for princesses.

How Woltemade deal could trigger ‘house-sale chain’ linked to Isak

Images courtesy of Getty
Since the Newcastle striker dropped his now-infamous “broken promises” statement ten days ago, Liverpool’s second bid for Alexander Isak has been unavoidable.

We are still waiting for the Premier League champions’ improved second offer, which came after their original £110 million offer was rejected on August 1st, with three days until the transfer window closes.

However, sources continue to say that it is only a matter of time before the Reds make a new deal, likely worth at least £120 million, to land Isak in what would be a British record deal.

And that action is the catalyst for a number of other transfers before Monday’s deadline.

Isak, Nick Woltemade, Yoane Wissa, Yvon Wissa, and Max Beier from Borussia Dortmund have to be in a house-sale chain, with all the necessary values, contracts, and moving dates planned for it to work.

Isak’s Instagram post, which read, “The relationship can’t continue,” is thought to be the start of a move by Liverpool to resume their search for the Sweden international.

Despite Newcastle’s efforts to reach a resolution earlier this week, the 25-year-old’s family has confirmed to BBC Sport that his intention is still to relocate to Anfield.

The only thing left is for Liverpool to submit what they believe to be a successful second bid for Isak, which has been a process for some time, according to sources.

Woltemade was Newcastle’s first move in a club record deal worth up to £69 million, making the chain the first to go on Saturday.

Before Isak’s desire to join Liverpool in the upcoming days, the first of three dominoes may need to fall.

The club made it clear in Newcastle’s response to Isak’s seismic post last week that “the conditions of a sale this summer have not occurred,” before saying that they did not “foresee those conditions being met.”

Those conditions triple. Newcastle will sign two strikers after the first two.

Woltemade is the first of those. The fact that Newcastle paid a club record fee for the German international suggests that Isak is entering the first-choice striker category, which Isak would normally hold.

Although Woltemade chose to use 27 instead of Isak’s number nine shirt.

Yoane Wissa, a forward from Brentford who has been hailed as the replacement for Callum Wilson since his departure, is still wanted by Newcastle.

The Magpies have already turned down two offers for Wissa from Brentford, the most recent of which was worth $35 million plus £5 million in additions.

According to sources close to the deal, the transfer will accelerate once Brentford sign another attacker following their capture of Bournemouth forward Dango Ouattara.

As Dortmund close negotiations with Brentford for Wolves attacker Fabio Silva, Dortmund are also interested in a move Beier.

Wissa is anticipated to relocate to St James’ Park if Beier joins Brentford.

Jorgen Strand Larsen is also a target for Newcastle, despite the club’s steadfast stance that the Norwegian international is not for sale. The Magpies have already rejected two bids from the club.

With Liverpool seeking Isak, Wissa or Larsen would become the second domino.

the third ? agreeing a deal between the clubs.

Newcastle’s willingness to sell Isak, who is still training with Eddie Howe’s squad, is evidenced by the fact that they are actively looking to sign two forwards.

related subjects

  • Liverpool
  • Premier League
  • Newcastle United
  • Football

How Woltemade deal could trigger ‘house-sale chain’ linked to Isak

Images courtesy of Getty
Since the Newcastle striker dropped his now-infamous “broken promises” statement ten days ago, Liverpool’s second bid for Alexander Isak has been unavoidable.

We are still waiting for the Premier League champions’ improved second offer, which came after their original £110 million offer was rejected on August 1st, with three days until the transfer window closes.

However, sources continue to say that it is only a matter of time before the Reds make a new deal, likely worth at least £120 million, to land Isak in what would be a British record deal.

And that action is the catalyst for a number of other transfers before Monday’s deadline.

Isak, Nick Woltemade, Yoane Wissa, Yvon Wissa, and Max Beier from Borussia Dortmund have to be in a house-sale chain, with all the necessary values, contracts, and moving dates planned for it to work.

Isak’s Instagram post, which read, “The relationship can’t continue,” is thought to be the start of a move by Liverpool to resume their search for the Sweden international.

Despite Newcastle’s efforts to reach a resolution earlier this week, the 25-year-old’s family has confirmed to BBC Sport that his intention is still to relocate to Anfield.

The only thing left is for Liverpool to submit what they believe to be a successful second bid for Isak, which has been a process for some time, according to sources.

Woltemade was Newcastle’s first move in a club record deal worth up to £69 million, making the chain the first to go on Saturday.

Before Isak’s desire to join Liverpool in the upcoming days, the first of three dominoes may need to fall.

The club made it clear in Newcastle’s response to Isak’s seismic post last week that “the conditions of a sale this summer have not occurred,” before saying that they did not “foresee those conditions being met.”

Those conditions triple. Newcastle will sign two strikers after the first two.

Woltemade is the first of those. The fact that Newcastle paid a club record fee for the German international suggests that Isak is entering the first-choice striker category, which Isak would normally hold.

Although Woltemade chose to use 27 instead of Isak’s number nine shirt.

Yoane Wissa, a forward from Brentford who has been hailed as the replacement for Callum Wilson since his departure, is still wanted by Newcastle.

The Magpies have already turned down two offers for Wissa from Brentford, the most recent of which was worth $35 million plus £5 million in additions.

According to sources close to the deal, the transfer will accelerate once Brentford sign another attacker following their capture of Bournemouth forward Dango Ouattara.

As Dortmund close negotiations with Brentford for Wolves attacker Fabio Silva, Dortmund are also interested in a move Beier.

Wissa is anticipated to relocate to St James’ Park if Beier joins Brentford.

Jorgen Strand Larsen is also a target for Newcastle, despite the club’s steadfast stance that the Norwegian international is not for sale. The Magpies have already rejected two bids from the club.

With Liverpool seeking Isak, Wissa or Larsen would become the second domino.

the third ? agreeing a deal between the clubs.

Newcastle’s willingness to sell Isak, who is still training with Eddie Howe’s squad, is evidenced by the fact that they are actively looking to sign two forwards.

related subjects

  • Liverpool
  • Premier League
  • Newcastle United
  • Football

The military-police pipeline

Domestic police forces’ arsenals increasingly include weapons of war.

Few people in Bangladesh are as aware of that as protesters. Up to 1,400 people were killed, according to the UN during the student uprising in 2024, the majority of whom were killed by state security forces.

However, police forces in more powerful regions of the world have started to appear and act more like armies over the past few decades. The United States has been the model for how military strategies and tactics for remote conflicts have been translated back into their native tongues and taken to civilian life.

Who can get updated COVID-19 vaccines in the US now?

Winter is approaching in the United States and COVID-19 cases are rising. Questions about accessing protective vaccines are swirling.

Nearly five years since the first US patient was vaccinated to help stem what was then a raging coronavirus pandemic, doctors, patients and pharmacists are navigating a radically different public health landscape.

The US Food and Drug Administration (FDA) on August 27 announced it had approved some COVID-19 vaccines – but for far fewer people than in years past.

If you tried to schedule a COVID-19 vaccine this week, your pharmacy’s online scheduler might have told you it isn’t available yet.

Meanwhile, leading medical organisations disagree with the government’s latest COVID-19 vaccine guidance.

If all that leaves you wondering about your ability to get a COVID-19 shot, you’re not alone. It’s confusing.

We sought answers.

Q: Who can get a COVID-19 vaccine?

First, what we do know: The FDA approved the 2025-26 vaccines for anyone age 65 and older and any person six months and older who has at least one underlying health condition that increases their risk of severe COVID-19 infection.

So, people in those groups should be able to schedule vaccinations as soon as healthcare providers who are authorised to administer the vaccine receive it – likely in the next few weeks.

Q: I don’t fit into those categories. Am I banned from getting a COVID-19 vaccine?

Not “banned”, per se. But it may require more legwork on your end. You’ll need to consult your doctor, who can legally prescribe a COVID-19 vaccine for you even if you don’t fall within the categories the FDA specified.

“Physicians can prescribe medications and vaccines that are beyond the label, beyond the licence,” said Dr William Schaffner, Vanderbilt University Medical Center professor of infectious diseases.

That’s true for adults and children – and the practice of prescribing medications and vaccines for “off-label” use is fairly common in paediatrics, he said.

Q: OK, so will insurance still cover COVID-19 vaccinations under these new rules?

If you’re in one of the two FDA-approved categories, the outlook is probably better than if you’re not.

Federal law requires that most health insurance plans fully cover vaccines recommended by the US Centers for Disease Control and Prevention and its vaccine advisory committee.

Here’s the rub: Because the CDC hasn’t yet adopted 2025-26 COVID-19 vaccine recommendations, whether the shots will be covered by insurance is a grey area.

The CDC’s panel of experts, the Advisory Committee on Immunisation Practices (ACIP), had planned to vote on updated COVID-19 vaccine recommendations at its June meeting, but did not. And it’s unclear when or if the ACIP will vote on the recommendations.

But there could be another avenue for people to get insurance-covered COVID-19 vaccines. The CDC’s vaccine recommendations typically include a provision for what’s known as “shared clinical decision making”, Schaffner said.

That means, for example, “If you were 52 years old and otherwise healthy, but you nonetheless wanted to get the vaccine, you could discuss that with your doctor – shared clinical decision-making – and you could receive the vaccine, and insurance companies would honour that,” he said.

That provision could be important for healthy people who want to avoid COVID-19 infection because they are close contacts with or care for people with high-risk conditions.

But again, without CDC recommendations, “We don’t know if that provision is still there,” Schaffner said.

To confirm whether your insurance will cover your COVID-19 shot, Schaffner recommends talking to your doctor and, potentially, your insurance provider. But first, give it a little more time: healthcare providers themselves are still working out the details.

Q: If my insurance doesn’t cover vaccination, how much might it cost?

Vaccine manufacturers report that COVID-19 vaccines cost about $142, according to the CDC’s price lists. It’s unclear whether that would be the out-of-pocket cost for patients receiving a COVID-19 vaccine not covered by insurance.

Q: Are COVID-19 vaccines still recommended during pregnancy? And if I’m pregnant and want one, what can I do? 

Health and Human Services Secretary Robert F Kennedy Jr in May announced he had unilaterally removed COVID-19 vaccines from the recommended immunisation schedule for healthy children and pregnant women. The health-focused news outlet STAT reported that no one from the CDC or ACIP was consulted before Kennedy announced this change. Vaccine experts called the move concerning and unprecedented.

Removing the vaccines from the immunisation schedule could limit vaccine access by reducing insurance companies’ coverage of the shot. But again, by consulting with your doctor, you might still be able to access it. Some pharmacies also might be able to provide it, because the CDC lists pregnancy as a factor that increases the risk of severe COVID-19 infection.

Q: Is there anyone who should not get the COVID-19 shot?

Broad health guidance always comes with exceptions. For example, people who have had “a very severe adverse reaction to a previous COVID-19 vaccine” should not get this season’s version, Schaffner said. You should discuss your health situation with your physician for personalised guidance.

Q: Why is the outlook for COVID-19 vaccines so different this year?

In short, Kennedy has long been broadly critical of vaccinations and, now that he’s in charge of the nation’s healthcare policy, has taken actions to overhaul their regulation and distribution.

Typically, the CDC recommends vaccines based on guidance from ACIP. ACIP’s recommendations become CDC policy if they’re adopted by the CDC director. This year, Kennedy fired all 17 members of ACIP and replaced them with new members, many of whom have expressed anti-vaccine views. CDC Director Susan Monarez was fired on August 27 amid a dispute with Kennedy over vaccine policy.

In previous years, the CDC recommended annual COVID-19 vaccines for everyone aged six months and older. The committee still hasn’t issued COVID-19 vaccine recommendations for this year.

Q: Aren’t there some medical organisations that recommend COVID-19 vaccinations for most people, though? 

Yes. In recent months, professional organisations have issued their own recommendations that contradict new messaging from the federal government.

The American Academy of Pediatrics recommends routine COVID-19 vaccines for all children aged six months to 23 months and for children aged two to 18 in some situations, including if they’re at high risk of COVID-19, have never been vaccinated against it or live in a household with people who are high risk.

And the American College of Obstetricians and Gynecologists recommends that anyone pregnant or lactating receive updated or “booster” COVID-19 vaccines.

Dr Tina Tan, president of the Infectious Disease Society of America, said the FDA’s decision to limit the COVID-19 vaccine’s approval “contradicts the evidence base, severely undermines trust in science-driven policy and dangerously limits vaccine access”.

Q: What qualifies as an underlying health condition that puts someone at higher risk? 

The FDA and HHS did not point us to a list of health conditions that meet the high-risk requirements.

The CDC’s website catalogues a number of underlying conditions that it said demonstrate “a conclusive increase in risk for at least one severe COVID-19 outcome”. They included: chronic lung diseases, cancer, certain chronic kidney and liver diseases, diabetes, some disabilities, heart conditions, HIV, physical inactivity, primary immunodeficiencies and some mental health conditions.

Q: But I clicked on those lists and both say ‘pregnancy and recent pregnancy’ are risk factors. How do I square that with the latest changes?

You’re right. These lists are inconsistent with the messaging coming from top HHS officials. Again, the American College of Obstetricians and Gynecologists continues to recommend COVID-19 vaccines for people who are pregnant and lactating. Talk to your doctor.

Q: Is this season’s COVID-19 vaccine formula different from last season’s?

Yes. After the FDA passed its recommendations to vaccine manufacturers in May, the COVID-19 vaccines were updated to target the viral strain expected to circulate this year. The changes align with the World Health Organization’s recommendations.

Q: When will the updated COVID-19 shots be available? 

Since the FDA’s approval, updated vaccines are set to start shipping immediately and might even be available now in some pharmacies. Pfizer said it was shipping immediately and would be available across the US “in the coming days”. Sanofi, the company distributing the Novavax non-mRNA vaccines, said its vaccine should be available “in the early fall”.

But what that means for how quickly you can access it could depend on where you live, your age and your health. (See next question.)

Q: Where can I get the updated COVID-19 shots? 

We knew you were going to ask. And we wish we had a straightforward answer.

If you typically get your COVID-19 shots at a local pharmacy, it might not be that easy this year.

As of August 29, the scheduling apps for Walgreens and CVS notified patients in some locations that they could not schedule a COVID-19 vaccine appointment because of state restrictions, inventory or the need for a prescription.

In 18 states and Washington, DC, pharmacists’ authority to administer vaccines is linked to the CDC’s recommendations, said Brigid Groves, the American Pharmacists Association’s vice president of professional affairs. The states are: Colorado, Connecticut, Georgia, Iowa, Kentucky, Maine, Maryland, Massachusetts, Montana, Nevada, New Jersey, New Mexico, North Carolina, Oregon, Pennsylvania, South Carolina, Virginia and West Virginia.

That means even though the FDA has issued its approval, in those 19 places, pharmacists cannot administer it because it isn’t on the CDC immunisation schedule yet, Groves said.

The American Pharmacists Association has asked those states’ governors to issue executive orders granting pharmacists broader authority to administer vaccines.

In the other 32 states, with some exceptions, it’s possible that a pharmacy can administer the updated COVID-19 shots for patients who fall within the FDA-approved categories of recipients.

If you are getting it “off label”, however, because you don’t have one of those underlying conditions, you might need to get it straight from your prescribing doctor.

One caveat: if ACIP votes on recommendations for COVID-19 vaccines that include giving them to healthy people through the “shared clinical decision making” process, Groves said pharmacists would be able to vaccinate almost anyone. That’s because pharmacists are considered clinicians who can conduct that shared decision-making.

Q: When might ACIP vote on COVID-19 vaccine recommendations? 

The committee has a September 18-19 meeting scheduled, according to the CDC’s website. A meeting agenda hasn’t been published yet.

Q: How will a pharmacy know if I have an underlying condition?

Typically, pharmacies ask patients to self-attest whether they have an underlying condition, Groves said. For example, a person who is under age 65 but has severe asthma would self-attest to that when making a vaccine appointment. So far, all signs point to that self-attestation still being the case.

Q: When is the best time to get vaccinated? 

During fall and winter months, when COVID-19 infections are typically expected to spike alongside other respiratory infections.

Q: What do the administration’s vaccine changes mean for future COVID-19 vaccines?

Kennedy recently cancelled $500m in funding for mRNA vaccine development. Two of the most effective COVID-19 vaccines are mRNA. Some companies had been researching combined mRNA flu and COVID-19 shots, and those projects’ status is unclear.

The FDA also recently announced that vaccine makers seeking approval for future COVID-19 vaccines, or boosters, would need to conduct new randomised clinical trials of healthy populations. That move, combined with the decision to narrow the FDA’s vaccine approval for certain segments of the population, is expected to limit COVID-19 vaccine access.